Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism.

Investigators conducted a meta-analysis of 4 randomized controlled trials including a total of more than 1000 men with prostate cancer.

From 2004-2009 to 2016-2020, the proportion of patients found to have high-risk and intermediate-risk prostate cancer after upfront radical prostatectomy increased from 16% to 27% and from 55% to 60%, ...

Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...

Adjuvant radiotherapy (RT) after radical prostatectomy did not improve outcomes in prostate cancer as compared with salvage RT but added toxicity, according to long-term follow-up from a randomized ...

Impact of a rash management guide on incidence and severity of rash with apalutamide: Experience from the Apa-RP study in high-risk localized prostate cancer. This is an ASCO Meeting Abstract from the ...

Up to 72% of patients with prostate cancer who undergo radical prostatectomy experience urinary incontinence in the first 3 months after surgery. Up to 72% of patients experience urinary incontinence ...

Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function. Researchers have found that the use of the NeuroSAFE technique to guide ...

Soputro delivered a podium presentation comparing outcomes between transvesical (TV) and extraperitoneal (EP) approaches for single-port robotic-assisted radical prostatectomy (SP-RARP). As ...